stockrowCuris, Inc. (CRIS) vs Ensysce Biosciences, Inc. (ENSC)
- Curis, Inc. CRIS 0.88 +3.53%
- Ensysce Biosciences, Inc. ENSC 0.34 −5.56%
Curis, Inc. and Ensysce Biosciences, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. is the larger, with a market value of $7.0M against $5.7M — 1.2× the size. Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −39.3%. Curis, Inc. has the higher net margin (0.00% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Curis, Inc. leads on 9 and Ensysce Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | CRIS | ENSC | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | 100.00% | 65.16% |
| Operating margin | 0.00% | (281.32%) | 0.00% |
| Net margin | 0.00% | (280.49%) | 0.00% |
| Free cash flow margin | 0.00% | (196.76%) | 0.00% |
| Return on equity | 455.35% | (1,295.01%) | (50.12%) |
| Return on assets | (87.76%) | (295.92%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack